Stroke is the 5th leading cause of death and the leading cause of disability in the US, but can we do more to improve those statistics? The answer is yes! The DAWN and DEFUSE-3 Trials have expanded the window for Endovascular Thrombectomy up to 24 hours for patients with Large Vessel Occlusion (LVO). While LVOs only account for approximately 1/3 of all strokes, they account for 60% of all disability and 90% of all mortality. Endovascular Thrombectomy can change those outcomes.
With so much potential for quality outcome improvement, society-sponsored advocacy is proving very successful in influencing legislative changes, including mandating suspected LVO patients be taken to the nearest Thrombectomy Capable Center. Even where legislative changes have not yet occurred, many EMS providers have begun adopting these protocols. The potential loss of this inbound EMS traffic may affect your bottom line. Corazon experts explored the important value of adding Thrombectomy services to your organization.
During this webinar, our experts:
Organizations that have already completed the foundational work associated with a formal stroke program are often much better positioned for neuro-interventional program implementation than they perceive. Position your neuroscience program for future growth and success by adding Thrombectomy!
*Please note: Your request will not be available immediately; rather, the webinar download is pending approval. You will receive an email with a digital download link to obtain your resource.
Disclaimer: Please note that Corazon Webinars are intended for individuals affiliated with hospitals, health systems, physician practices, and other healthcare delivery organizations. We apologize for any inconvenience.